Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Ergi3/Ergic-3 (AA 301-383) anticorps (AbBy Fluor® 350)

L’anticorps Lapin Polyclonal anti- a été validé pour WB, IF (cc) et IF (p). Il convient pour détecter dans des échantillons de Humain.
N° du produit ABIN1693973

Aperçu rapide pour Ergi3/Ergic-3 (AA 301-383) anticorps (AbBy Fluor® 350) (ABIN1693973)

Antigène

Ergi3/Ergic-3

Reactivité

Humain

Hôte

  • 14
Lapin

Clonalité

  • 14
Polyclonal

Conjugué

  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
AbBy Fluor® 350

Application

  • 14
  • 12
  • 12
  • 3
  • 3
  • 3
  • 1
Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Épitope

    AA 301-383

    Homologie

    Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human ERGI3/ERGIC-3

    Isotype

    IgG
  • Indications d'application

    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Date de péremption

    12 months
  • Antigène

    Ergi3/Ergic-3

    Sujet

    Synonyms: 2310015B14Rik, AV318804, C20orf47, CGI 54, D2Ucla1, dJ477O4.2, DKFZp547A2190, Endoplasmic reticulum Golgi intermediate compartment protein 3, endoplasmic reticulum localized protein ERp43, Endoplasmic reticulum-Golgi intermediate compartment protein 3, ERGI3_HUMAN, ERGIC and golgi 3, ergic3, ERV46, NY BR 84, PRO0989, RP23-220D12.2, RP3-477O4.1, SDBCAG84, serologically defined breast cancer antigen 84, Serologically defined breast cancer antigen NY BR 84, Serologically defined breast cancer antigen NY-BR-84.

    Background: Cycling proteins play important roles in the organization and function of the early secretory pathway by participating in membrane traffic and selective transport of cargo between the endoplasmic reticulum (ER), the intermediate compartment (ERGIC), and the Golgi. A family of membrane bound, ubiquitous proteins involved in the selective transport of newly synthesized glycoproteins from the ER to the ERGIC include VIP36, ERGIC-53, ERGIC-1, ERGIC-2 and ERGIC-3. ERGIC-1, also designated ERGIC32, is thought to modulate the activity of a complex formed by ERGIC-2, also designated Erv41, and ERGIC-3, also designated Erv46. ERGIC-2 and ERGIC-3 are both mammalian homologs of yeast proteins abundant in COPII-coated vesicles and localize to the Cis-face of the Golgi apparatus.

    ID gène

    51614
Vous êtes ici:
Chat with us!